Latest Press Releases
More Press Releases
GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027
Comprehensive clinical and scientific data supporting Phase 2 development of nangibotide in ACLF unveiled to leading
CNH Announces Agreement to Form a Joint Venture by Selling a 70% Interest in its Construction Equipment Business to Kobelco Construction Machinery
CNH Announces Agreement to Form a Joint Venture by Selling a 70% Interest in its Construction Equipment Business to
Return of the Cheetah: Bloodlines Premieres Globally, Documenting the Conservation of Cheetah Genetic Diversity
WUHU, China, Nov. 09, 2026 (GLOBE NEWSWIRE) — Recently, Return of the Cheetah: Bloodlines, the third season of the
Helping AI Recommend Quality Brands Accurately: Second GEO Conference Opens in Shenzhen on November 21
The two-day program covers enterprise GEO strategy, trusted sources from mainstream media, data monitoring,
Unnatural Products to be Acquired by argenx for up to $1.15 Billion to Advance Next-Generation Medicines
Argenx to acquire UNP for $550 million upfront plus contingent value rights tied to development and regulatory
From Hobby to Small Business: ToAuto Launches #ToAutoMade 2026 Maker Challenge
The global creative challenge brings together candle makers, lapidary artists, and metalworking creators to share real
argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities
Pairs Unnatural Products’ (UNP) peptide expertise with argenx's antibody engineering, expanding the ways to target
Essential Pharma and Nordmark announce new partnership and UK availability of Norzyme® (pancreas powder) 25,000 gastro-resistant capsules for pancreatic exocrine insufficiency
Partnership brings together decades of pancreatin experience at Nordmark and Essential PharmaNorzyme® (pancreas
Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2
Data from infant immunogenicity and safety trial, and controlled human infection model (CHIM) trial, demonstrate
Mitsubishi Electric Achieves World’s First Demonstration of Suppression of Frequency Dispersion in GaN Transistors Using GaN Substrates
Contributing to improved performance and lower power consumption of high-frequency equipment by demonstrating the